Perinatal Stem Cells

<p>Section I. Amniotic Fluid-Derived Stem Cells</p> <p>1. In utero therapy for congenital disorders using amniotic fluid stem cells</p> <p>2. The Amniotic Fluid Stem Cell Secretome: at the Heart of Regeneration</p> <p>3. Transplantation of Amniotic Fluid-Derived Neural Stem Cells</p> <p>4. Stroke therapy: the potential of amniotic fluid-derived stem cells </p> <p>5. Vascular formation by human perinatal stem cells</p> <p>6. Amniotic Fluid Stem Cells for Kidney Regeneration</p> <p>Section II. Placental and Placental Membrane-Derived Stem Cells</p> <p>7. Placental mesenchymal stem cells for cellular cardiomyoplasty</p> <p>8. Heterogeneous functions of perinatal mesenchymal stromal cells require a preselection before their banking for clinical use </p> <p>9. Defining the fetal stem cell niche in the human placenta</p> <p>10. Banking placental tissue hematopoietic stem cells and mesenchymal stem cells for clinical use</p> <p>11. Immuno-modulatory mechanisms of placental stem cells</p> <p>12. Amnion Membrane Allograft for Regenerative Medicine</p> <p>13. Perinatal cells and biomaterials for wound healing</p> <p>14. Placental Stem Cells</p> <p>15. Therapeutic Effect of Extracellular Vesicles Derived from Adult/Perinatal Human Mesenchymal Stem Cells</p> <p>Section III. Umbilical Cord-Derived Cells</p> <p>16. Ex-vivo Expansion of Cord Blood Stem Cells</p> <p>17. Cord Blood Transplantation: Therapeutic Use of Perinatal Stem Cells </p> <p>18. Autologous Human Cord Blood as a Treatment for Traumatic Brain Injury in Children</p> <p>19. Phenotypic and Functional Characterization Perinatal Stem Cells Isolated from Umbilical Cord Tissue</p> <p>20. Mesenchymal stromal cells from Wharton’s jelly (WJ-MSCs): coupling their hidden differentiative program with their frank immunomodulatory phenotype</p> <p>21. Regeneration of ischemic cardiovascular damage using Jelly Wharton as an unlimited source of therapeutic stem cells</p> <p>22. Phenotype with Focused Paracrine Fractions: Effecting Future Phenotype with Focused Paracrine Fractions</p> <p>Section IV. Clinical and Industry Perspective</p> <p>23. Clinical Translation of Perinatal Stem Cell Therapy </p> <p>24. Current Clinical Trials utilizing Perinatal Stem Cells – A Review </p> <p>25. Review Of Processing Technology and Techniques for Perinatal Stem Cells Banking And Clinical Applications</p> <p>26. Clinical Development And Commercialization Of Placenta-Derived Cell Therapy </p> <p>27. How the patent landscape has changed</p> <p>28. The Need for Better Assays to Predict the Effectiveness of Tissue Stem Cell Treatments</p>